Related Experiment Video

Updated: Aug 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta

Hideaki Ijichi1, Motoyuki Otsuka, Keisuke Tateishi

  • 1Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. ijichi-2im@h.u-tokyo.ac.jp

Oncogene
|February 6, 2004
PubMed

Insights

Transforming growth factor-beta (TGF-beta) signaling regulates cell growth. This study reveals a novel Smad4-independent pathway for TGF-beta to control gene expression, impacting pancreatic cancer research.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • The transforming growth factor-beta (TGF-beta)-Smad signaling pathway is crucial for inhibiting human epithelial cell growth and tumor suppression.
  • Mutations or deletions in the Smad4 gene are frequently observed in pancreatic cancers, highlighting its importance in this disease.

Purpose of the Study:

  • To investigate the Smad4-dependent and -independent target genes regulated by TGF-beta in pancreatic cancer cells.
  • To elucidate the signaling mechanisms by which TGF-beta influences gene expression in a Smad4-null context.

Main Methods:

  • Utilized a Smad4-null pancreatic cancer cell line (BxPC-3) transfected with Smad4 or empty vectors.
  • Employed cDNA microarray analysis of 2280 genes and quantitative RT-PCR to identify TGF-beta-regulated genes.
  • Investigated the transcriptional regulation of the p21/WAF1 promoter.

Main Results:

  • TGF-beta upregulated only one gene via Smad4-independent signaling and one gene via Smad4-dependent signaling out of 2280 screened genes.
  • The cyclin-dependent kinase inhibitor p21/WAF1 was upregulated in a Smad4-independent manner.
  • This upregulation was mediated by Smad2/3-dependent transcriptional activation of the p21/WAF1 promoter.

Conclusions:

  • TGF-beta can regulate gene expression through Smad4-independent pathways, which may be as significant as Smad4-dependent pathways.
  • A novel mechanism of gene regulation involving a signal mediator other than Smad4 was identified.
  • These findings suggest new therapeutic targets for pancreatic cancer by understanding alternative TGF-beta signaling routes.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...